The “Business” magazine published the issue “Innovations. Push the boundaries.”, dedicated to innovations introduced by the Ukrainian companies. Farmak was nominated for “Innovative Leadership”
“This “Innovative Leadership” nomination is in line with the course for development chosen by Farmak. We are trying to create an innovation-friendly culture in our company. The goal is to encourage the top managers, mid-level experts and specialists to think about solutions that can be implemented most effectively. We are implementing a lot of automation in the new projects. These are the various Manufacturing Execution System combinations, electronic batch records, datasheets, barcoding, etc. We have used our best efforts to digitize our processes. We work with SAP. Last year we introduced a modern manufacture planning system and a system that helps us to plan the development and evaluation of our employees”, said Volodymyr Kostiuk, Executive Director of JSC “Farmak”.
Farmak, as a member of the European Generic Medicines Association (EGA) – Medicines for Europe – and the Association of “Manufacturers of Drugs of Ukraine” (the AMDU), advocates for the creation of a coordination group at the Office of the President of Ukraine to prevent a shortage of medicines in Ukraine during the pandemic. […]
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]